UPB Upstream Pharma Earnings per share growth this year
Upstream Bio Inc (UPB) is establishing a foundation for inflammation therapy via TSLP inhibitors to combat asthma. Patent protection for monoclonal drugs strengthens the firm's position within the biotechnology sector. Scientific partnerships with laboratories are accelerating the launch of immunological products. Annual EPS progress demonstrates shareholder return dynamics, where the -7.90 mark reflects the latest earnings data.
Analytical breakdowns and data insights for company Upstream Bio Inc (UPB)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Aggregate Debt to Equity Upstream Bio Inc|UPB - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient upstreambio.com|UPB - Company Total Debt|Debt to Book Capital Upstream Pharma|UPB - Company Long-Term Debt|Company Short-Term Loans and Borrowings Upstream Bio|Immediate Liquidity upstreambio.com
- company profitability and valuation multiples indicators:
UPB - Net Profit|Projected Future Earnings Upstream Bio Inc|UPB - Price to Earnings Ratio|Projected Price to Earnings Upstream Pharma|UPB - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Upstream Pharma|UPB - Operating profit EBITDA|Earnings per share for the last twelve months Upstream Bio|UPB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months upstreambio.com|UPB - Earnings per share growth in current year|Expected net earnings per share growth next year Upstream Bio Inc
Summary company analysis:Upstream Bio, Inc. - UPB
This indicator measures the annual growth of earnings per share, allowing for an assessment of capital generation efficiency relative to the previous period. By analyzing the year-over-year EPS comparison, an investor can see that for Upstream Bio Inc (UPB) at the clinical trial stage, this metric is secondary, as the commercial success of the asthma treatment ecosystem depends entirely on the FDA verdict.
Main competitors
argenx N.V. (ARGX) - Earnings growth in current year|Earnings per share growth in current year BioNTech Group|Earnings per share growth this year ABVX (abivax.com)|Earnings growth in current year ADMA|PTGX - Earnings per share growth rate in current year|Immunovant - Net earnings per share growth this year|Earnings growth in current year Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Earnings per share growth in current year|Earnings per share trend in current year ADPT|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|AUPH - Expected net earnings per share growth this year|Net earnings per share growth this year BCRX|VERA (Vera Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings per share growth in current year Dianthus Pharma (DNTH)|PHVS (Pharvaris Pharma) - Earnings per share increase in current year|Earnings growth in current year ABCL (AbCellera Biologics)|tourmalinebio.com (TRML) - Earnings per share growth rate in current year|Precigen - Earnings growth in current year|PHAR - Earnings growth in current year|Nektar (NKTR) - Earnings per share growth in current year|Net earnings per share growth this year Zenas Corp|Net earnings per share growth this year IMNM|GOSS: Earnings per share increase in current year|Earnings growth in current year KALV|Earnings per share growth in current year SEPN (Septerna, Inc.)|Earnings growth in current year PVLA (Pieris Pharmaceuticals Inc)|Expected net earnings per share growth this year Savara Pharma (SVRA)|RIGL - Earnings per share growth in current year|Earnings per share growth rate in current year anaptysbio.com|ATXS (Astria Therapeutics, Inc.) - Net earnings per share growth this year|enGene Holdings Inc - Earnings per share increase in current year|RAPT (RAPT Therapeutics) - Earnings growth in current year|Aerovate (JBIO) - Expected net earnings per share growth this year|Earnings per share growth in current year Aclaris Therapeutics (ACRS)|kyvernatx.com - Earnings per share growth this year|Earnings growth in current year TLSA (Tiziana Life Sciences Ltd)|CABA - Net earnings per share growth this year|VTYX: Net earnings per share growth this year|THTX - Earnings growth in current year|Avalo Therapeutics, Inc (AVTX) - Earnings per share growth in current year|Earnings per share trend in current year ELDN (eledon.com)|AGEN (Agenus Inc.) - Earnings growth in current year|Earnings per share growth in current year CLYM|Earnings per share growth in current year Zura Bio (ZURA)|ATYR: Earnings per share trend in current year|Earnings growth in current year ADAG (Adagene Inc.)|Earnings per share increase in current year IMA|Shattuck Therapeutics - Earnings growth in current year|EQ - Earnings growth in current year|connectbiopharm.com (CNTB) - Earnings per share growth in current year|Immunic - Earnings per share increase in current year|Earnings per share growth in current year Atara Biotherapeutics, Inc.|Net earnings per share growth this year InflaRx GmbH (IFRX)|Earnings growth in current year XFOR|Earnings growth in current year adicetbio.com (ACET)|Celularity - Net earnings per share growth this year|Earnings per share increase in current year INMB|Barinthus Biotherapeutics - Earnings growth in current year|Expected net earnings per share growth this year kezarlifesciences.com KZR|SAB Biotherapeutics, Inc. (SABS) - Earnings per share growth in current year|Net earnings per share growth this year Akari Therapeutics PLC|Earnings per share growth in current year Enlivex Therapeutics Ltd|Net earnings per share growth this year Q32 Bio Corp (QTTB)|Net earnings per share growth this year GOVX (GeoVax Labs, Inc.)|Earnings growth in current year edesabiotech.com (EDSA)|Earnings per share growth in current year iBio IBIO|CARM: Earnings per share growth this year|XTL Biopharmaceuticals, Ltd. - Earnings growth in current year|Earnings per share growth rate in current year Bolt Biotherapeutics|HCWB (hcwbiologics.com) - Net earnings per share growth this year|Aptevo Therapeutics Inc. (APVO) - Earnings growth in current year|Earnings per share growth in current year AIM ImmunoTech Inc.|Aditxt Corp - Earnings per share trend in current year|Earnings per share growth in current year GRI Bio Corp (GRI)|Expected net earnings per share growth this year XORTX Corp|Vyome Holdings Inc - Net earnings per share growth this year|Net earnings per one share growth for the current year REVB (revbiosciences.com)|INDP - Earnings per share growth in current year|Earnings per share increase in current year SCNI (Scinai Immunotherapeutics Ltd)|CALI: Earnings growth in current year|Earnings per share growth rate in current year Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Earnings growth in current year|Earnings growth in current year HOOKIPA|Earnings per share growth in current year IGM Biosciences, Inc. (IGMS)|Net earnings per share growth this year iTeos Therapeutics Inc ITOS|Ocean Bio - Net earnings per share growth this year|Earnings per share increase in current year TCBP|Third Harmonic Bio - Earnings growth in current year
